Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Davide

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Science (New York, N.Y.)|February 15, 1991
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarificationsG J LaRosa, J P Davide, K Weinhold, et al.
Nature Medicine|August 1, 1995
Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic miceN E Kohl, C A Omer, M W Conner, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2001
Diaryl ether inhibitors of farnesyl-protein transferaseS C Mactough, S J Desolms, A W Shaw, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-IJ M Bergman, M T Abrams, J P Davide, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Oxo-piperazine derivatives of N-arylpiperazinones as inhibitors of farnesyltransferaseC J Dinsmore, J M Bergman, D D Wei, et al.
Journal of Medicinal Chemistry|March 29, 1996
2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferaseT M Williams, T M Ciccarone, S C MacTough, et al.
Cancer Research|December 26, 2001
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical modelsR B Lobell, C A Omer, M T Abrams, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferaseD C Beshore, I M Bell, C J Dinsmore, et al.
Cancer Research|May 29, 2000
Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitorC A Omer, Z Chen, R E Diehl, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Science (New York, N.Y.)|February 15, 1991
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarificationsG J LaRosa, J P Davide, K Weinhold, et al.
Nature Medicine|August 1, 1995
Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic miceN E Kohl, C A Omer, M W Conner, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2001
Diaryl ether inhibitors of farnesyl-protein transferaseS C Mactough, S J Desolms, A W Shaw, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-IJ M Bergman, M T Abrams, J P Davide, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Oxo-piperazine derivatives of N-arylpiperazinones as inhibitors of farnesyltransferaseC J Dinsmore, J M Bergman, D D Wei, et al.
Journal of Medicinal Chemistry|March 29, 1996
2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferaseT M Williams, T M Ciccarone, S C MacTough, et al.
Cancer Research|December 26, 2001
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical modelsR B Lobell, C A Omer, M T Abrams, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferaseD C Beshore, I M Bell, C J Dinsmore, et al.
Cancer Research|May 29, 2000
Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitorC A Omer, Z Chen, R E Diehl, et al.
Pageof 3